Trial reportExperimental dermatology2025
Visible Light-Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment.
Trial report in Experimental dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 9 registered trials, which are not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessment of the Protective Effect of Four Sunscreens on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Assessment of the Protective Effects of Three Sunscreen Products on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Assessment of the Protective Effect of a Sunscreen on Visible Light Induced Pigmentation Using Two Different Simulators, Compared with an Untreated Control Zone
Assessment of the Protective Effect of Different Topical Agents on Visible Light Induced Pigmentation Compared with a Not Treated Control Zone
Assessment of the Protective Effects of Seven Sunscreen Products on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Assessment of the Protective Effect of Three Sunscreens on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Assessment of the Protective Effects of Three Sunscreen Products on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Assessment of the Protective Effect of Three Sunscreens on Visible Light Induced Pigmentation Compared with an Untreated Control Zone
Evaluation of the Protective Effect of Three Laboratoire VICHY Formulations on the Pigmentation Induced by Visible Light in Comparison with a Non-treated Control Zone
Who cites it
3 citing papers in PubMed.
- Visible Light-Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment.Experimental dermatology · 2025Trial
- Visible Light Protection Strategies for Diverse Populations.Dermatology and therapy · 2026Review
- Topical prevention from high energy visible light-induced pigmentation by 2-mercaptonicotinoyl glycine, but not by ascorbic acid antioxidant: 2 randomized controlled trials.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As hyperpigmentation can worsen with exposure to ultraviolet (UV) and visible light (VL), sunscreens with well-balanced UVB/UVA protection and VL-blocking pigments are recommended. Assessing efficiency against VL-induced pigmentation is then mandatory. Recently, an in vivo pigmentation assessment allowing a VL protection factor (pVL-PF) determination, and an in vitro predictive method based on transmittance measures were introduced. However, the number of volunteers, tested sunscreens, and protection range were limited. Moreover, no statistical assessment was associated. This study aimed at testing the robustness and improving these methodologies by conducting a series of 9 monocentric, double-blind, randomised controlled in vivo studies involving 188 volunteers and 30 products, alongside an in vitro approach, in 2 independent laboratories. Our results first allowed us to improve pVL-PF calculation by better fitting to VL-induced pigmentation dynamics. Based on the 30 established pVL-PF, we evidenced that VL-protection level strongly correlated with the amount of pigments in products. Second, a statistical Bayesian approach, accounting for kinetic and inter-individual response variability over time, was proposed. This enabled us to determine that 24 out of 30 products significantly reduced VL-induced pigmentation. Finally, we showed that in vitro transmittance reduction was highly predictive of in vivo results. In conclusion, through several independent studies involving a large number of products and volunteers, a refined pVL-PF calculation associated with statistical indicators was proposed together with a predictive in vitro assessment. These methodologies to assess the efficacy of tinted products against VL-induced pigmentation are complementary and could also be of interest for other pathologies induced or aggravated by VL. Trial Registration: NCT06827392, NCT06796192, NCT06803901, NCT06796140, NCT06796153, NCT06796010, NCT06796088, NCT06796205, NCT06796179.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.